全文获取类型
收费全文 | 902篇 |
免费 | 61篇 |
专业分类
耳鼻咽喉 | 1篇 |
儿科学 | 22篇 |
妇产科学 | 13篇 |
基础医学 | 136篇 |
口腔科学 | 91篇 |
临床医学 | 50篇 |
内科学 | 183篇 |
皮肤病学 | 59篇 |
神经病学 | 43篇 |
特种医学 | 8篇 |
外科学 | 161篇 |
综合类 | 8篇 |
一般理论 | 2篇 |
预防医学 | 92篇 |
眼科学 | 6篇 |
药学 | 47篇 |
中国医学 | 4篇 |
肿瘤学 | 37篇 |
出版年
2023年 | 7篇 |
2022年 | 31篇 |
2021年 | 26篇 |
2020年 | 23篇 |
2019年 | 26篇 |
2018年 | 45篇 |
2017年 | 24篇 |
2016年 | 37篇 |
2015年 | 39篇 |
2014年 | 56篇 |
2013年 | 46篇 |
2012年 | 62篇 |
2011年 | 73篇 |
2010年 | 54篇 |
2009年 | 32篇 |
2008年 | 51篇 |
2007年 | 32篇 |
2006年 | 37篇 |
2005年 | 32篇 |
2004年 | 21篇 |
2003年 | 31篇 |
2002年 | 22篇 |
2001年 | 13篇 |
2000年 | 19篇 |
1999年 | 15篇 |
1998年 | 7篇 |
1996年 | 2篇 |
1995年 | 3篇 |
1994年 | 2篇 |
1993年 | 2篇 |
1992年 | 11篇 |
1991年 | 6篇 |
1990年 | 5篇 |
1989年 | 3篇 |
1988年 | 4篇 |
1987年 | 5篇 |
1986年 | 4篇 |
1985年 | 4篇 |
1984年 | 6篇 |
1983年 | 5篇 |
1981年 | 2篇 |
1980年 | 4篇 |
1979年 | 3篇 |
1978年 | 3篇 |
1977年 | 2篇 |
1971年 | 2篇 |
1970年 | 6篇 |
1969年 | 7篇 |
1968年 | 3篇 |
1965年 | 3篇 |
排序方式: 共有963条查询结果,搜索用时 0 毫秒
71.
72.
Elio Hitoshi Shinohara Eduardo Hochuli Vieira Idelmo Rangel Garcia Júnior Ana Maria Pires‐Soubhia Marcelo Zillo Martini 《Dental traumatology》2010,26(4):351-352
Abstract – Dento‐alveolar process fracture is an important and common event in the dental office practice usually managed under the well‐established protocols, but sometimes this kind of lesion is evaluated in the hospital emergency rooms without attention to the dental injuries. In this type of trauma, the time between the injury and the definitive resolution is essential for the treatment success, usually 1 h in cases of dento‐alveolar fractures (tooth and alveolar bone). This paper describes the management of a patient with unusual dento‐alveolar fracture caused by gunshot and treated using screw fixation. 相似文献
73.
Sonia Marcos‐Alonso Nuria Gil Luis García‐Guereta Dimpna Albert María ngeles Tejero Flix Perez‐Villa Manuel Gmez Bueno Teresa Blasco Peir Ana Cano Beatriz Díaz Molina Diego Rangel Sousa 《Pediatric transplantation》2020,24(4)
Evidence on the impact of MCS on pediatric heart transplant survival is still scarce related to congenital heart disease patients including univentricular physiology as well as the risk factors for complications. We performed a retrospective review of all urgent pediatric (aged ≤16 years) HT from 2004 to 2014 in the Spanish Pediatric Heart Transplant Registry Group. Patients were stratified into two groups: urgent 0 (MCS at HT) and urgent 1 (non‐MCS at HT). The primary outcome measure was post‐transplant survival; secondary outcome measures were complications and absence of infections and rejection during the first post‐transplant year. One hundred twenty‐one pediatric patients underwent urgent HT, 58 (47.9%) urgent 0 and 63 (52%) urgent 1. There were 30 (24.8%) deaths: 12 in the urgent 0 group and 18 in the urgent 1 group, P = n.s. Regarding the type of MCS, patients on ECMO had the highest rate of complications (80%) and mortality (40%). Patients in the urgent 1 group showed a higher risk of hospital re‐admission for infection during the first year after transplantation (OR 2.31 [1.1‐4.82]), P = .025. We did not identify a risk factor for mortality. MCS does not impact negatively on survival after HT. However, there is a significant increase in 30‐day and 1‐year mortality and complications in ECMO patients compared with VAD patients. Infants, congenital heart disease, and PediMACS were not found to be risk factors for mortality. 相似文献
74.
75.
Gonzalo Garijo MA Pérez Calderón R de Argila Fernández-Durán D Rangel Mayoral JF 《Allergologia et immunopathologia》2005,33(4):238-240
BackgroundThe spectrum of cutaneous eruptions in association with calcium channel blockers is extensive, varying from exanthemas to severe adverse events. Reactions due to diltiazem occur more frequently than with other calcium channel blockers. Patch testing has been used as confirmatory testing in patients with extensive cutaneous reactions. Cross-reactivity among these drugs have not been established.MaterialWe present 3 patients: 1) A 54-year-old man developed a generalized eythema-multiformelike reaction followed by erythrodermia and exfoliative dermatitis 6-7 days after starting on diltiazem. The drug was stopped and remission was obtained with emollients and systemic corticosteroids and antihistamines within 12 days. 2) A 80-year-old woman experienced a pruritic exanthematous eruption on her trunk which evolved to generalized erythrodermia and superficial desquamation. This reaction appeared 10 days after taking diltiazem, and gradually improved in 10-12 days after discontinuation of this drug.3) A 79-year-old man presented with erythema and pruritus initially on the back, and then affecting thorax, extremities and face. He had started treatment with diltiazem three days before. Diltiazem was stopped and steroid and antihistamine therapy was given. His skin condition improved, but 3 days later the patient received verapamil with worsening of previous situation. He recovered within 7 days.Methods and resultsTwo to six months after the reaction, we carried out epicutaneous tests with calcium channel blockers from different groups. Diltiazem proved positive (at 48 and 96 hours) in the three patients; nifedipine was also positive in patient 2, and verapamil in patient 3. Controlled administration of verapamil was well tolerated in patient 2 after the reaction, and the patient 1 has taken nifedipine without problems.Conclusions1) We report 3 cases of cutaneous reactions due to diltiazem. 2) Epicutaneous tests have been useful for diagnosis. 3) As one of patients had positive patch tests to diltiazem and nifedipine, and other one with diltiazem and verapamil, more studies are needed to demonstrate cross reactions among calcium channel blockers. 相似文献
76.
Rangel A Basave M Lavalle C Hernández L Ochoa J Chávez E Albarrán H 《Archivos del Instituto de Cardiología de México》2000,70(1):66-71
This is the case of a 27 years-old woman with signs and symptoms of severe untreatable congestive heart failure, anemia, gingival mucosa ulcers, photosensitivity and alopecia. The electrocardiographic, echocardiographic, angiographic and hemodynamic data oriented the diagnosis of restrictive cardiomyopathy, mitral insufficiency secondary to mitral prolapse and bi-atrial dilation. The histologic study of the endomyocardial biopsy, performed during catheterization, showed signs of endomyocardial fibrosis, and immunological analysis was compatible with systemic lupus erythematosus. As far as we know, this is the first case of endomyocardial fibrosis (Davies disease) associated with systemic lupus erythematosus published in the medical literature. The etiology of Davies disease remains unrevealed and its association with systemic lupus erythematosus suggest a probable autoimmune origin. 相似文献
77.
Human epithelial beta-defensins 2 and 3 inhibit HIV-1 replication 总被引:26,自引:0,他引:26
Quiñones-Mateu ME Lederman MM Feng Z Chakraborty B Weber J Rangel HR Marotta ML Mirza M Jiang B Kiser P Medvik K Sieg SF Weinberg A 《AIDS (London, England)》2003,17(16):F39-F48
OBJECTIVE: Mechanisms underlying mucosal transmission of HIV-1 are incompletely understood. We describe the anti-HIV-1 activity of human beta-defensins (hBD), small cationic molecules that provide protection at mucosal surfaces. METHODS AND RESULTS: HIV-1 induced expression of hBD-2 and -3 mRNA (but not that of hBD-1) 4- to 78-fold, respectively, above baseline in normal human oral epithelial cells. HIV-1 failed to infect these cells, even after 5 days of exposure. Recombinant hBD-1 had no antiviral activity, while rhBD-2 and rhBD-3 showed concentration-dependent inhibition of HIV-1 replication without cellular toxicity. Inhibition was greater against CXCR4-tropic than against the CCR5-tropic HIV-1 isolates. hBD-2 and hBD-3 induced an irreversible effect on virion infectivity, with electron microscopy confirming binding of hBDs to viral particles. Finally, hBD-2 and -3 induced downmodulation of the HIV-1 coreceptor CXCR4 (but not CCR5) in peripheral blood mononuclear cells and T lymphocytic cells as shown by confocal microscopy and flow cytometry. CONCLUSIONS: This study shows for the first time that HIV-1 induces beta-defensin expression in human oral epithelial cells and that beta-defensins block HIV-1 replication via a direct interaction with virions and through modulation of the CXCR4 coreceptor. These properties may be exploited as strategies for mucosal protection against HIV-1 transmission. 相似文献
78.
Immunotopographic assessment of lymphoid and plasma cell malignancies in the bone marrow 总被引:4,自引:0,他引:4
Rene Kronland MD Thomas Grogan MD Catherine Spier MD Daniel Wirt HTL Catherine Rangel MT Lynne Richter MD Brian Durie MD Bernard Greenberg MD Thomas Miller MD Stephen Jones 《Human pathology》1985,16(12):1247-1254
To determine the utility of tissue section immunochemistry in the evaluation of bone marrow involved by lymphoid and plasma cell malignancies, snap-frozen, undecalcified bone marrow core and aspirate samples from 23 patients with these disorders were studied with a battery of monoclonal antibodies. With techniques that preserve architecture, difficult diagnostic cases characterized by core but not aspirate involvement, or the reverse, were resolved. By means of an extensive battery of monoclonal antibodies applied to serial sections, complex tumor cell phenotypes were established in all 23 cases. In addition to the identification of straightforward monoclonal surface immunoglobulin expression in small cleaved cell lymphomas (four cases), the battery approach added immunologic certainty in malignancies with unusual or difficult phenotypes: peripheral T-cell lymphomas with idiosyncratic antigen expression, and chronic lymphocytic leukemias and small cell lymphomas with faint surface immunoglobulin expression (four cases). For the chronic lymphocytic leukemias and the small cell lymphomas, the combined IgD+, B2+, B1+, Ia+, Leu-1+ phenotype taken as a whole had greater utility than any isolated marker. The acute lymphocytic leukemias and the myelomas studied demonstrate the wide range of B-cell antigens that must be detected to account for the variety of B-cell neoplasms encountered. Additionally, the previously undescribed phenotypic subset of CALLA+ myelomas, which is of prognostic relevance, was identified. Marrow frozen section immunotyping is a major asset in the evaluation of patients with lymphoma, leukemia, and myeloma when special care is accorded to tissue handling and to treatment of endogenous peroxidase/pseudoperoxidase and interstitial immunoglobulin. 相似文献
79.
Piñeyro-López A Pineyro-Garza E Torres-Alanís O Reyes-Araiza R Gómez Silva M Wacksman N Rangel RL de Lago A González-de la Parra M Namur S 《Clinical therapeutics》2005,27(10):1607-1611
BACKGROUND: Azithromycin is related to erythromycin but is more active against gram-negative bacteria and less active against streptococci and staphylococci compared with erythromycin. For these reasons, and because of convenience of dosing (QD for 3 days), azithromycin is widely used in Mexico. Although several generic formulations of azithromycin are available in Mexico, information concerning the bioavailability of each formulation in the Mexican population is not available. OBJECTIVE: The aim of this study was to compare the bioavailability and tolerability of 2 oral formulations of azithromycin 500 mg used in Mexico: Macrozit (trademark of Laboratorios Liomont, S.A. de C.V., Mexico City, Mexico; test formulation) and Azitrocin (trademark of Pfizer, S.A. de C.V., Mexico City, Mexico; reference formulation). METHODS: This 2 x 2, crossover, randomized, open-label study was conducted at the Department of Pharmacology and Toxicology, Universidad Autóma de Nuevo Leon, Monterrey, Mexico. Eligible subjects were healthy volunteers of either sex and with the following characteristics: age > or =19 to 25 years, weight 54 to 77 kg, and height 159 to 177 cm. Subjects were randomly assigned to receive Macrozit followed by Azitrocin, or vice versa, with a 3-week washout period between doses. After a 12-hour (overnight) fast, subjects received a single, 500-mg dose of each formulation. For analysis of pharmacokinetic properties, including C(max), AUC(0-t), and AUC(0-infinity), blood samples were drawn at 0.5, 1, 1.5, 2, 2.5, 3, 4, 6, 12, 24, 48, 72, 96, and 120 hours after dosing. The formulations were considered bioequivalent if the logarithm (ln)-transformed ratios of C(max) and AUC were within the predetermined equivalence range of 80% to 125% and if P < or = 0.05 for the 90% CIs. Tolerability was assessed by monitoring and subject interview regarding the potential presence of adverse events (AEs). RESULTS: Twenty-eight subjects were enrolled in the study; 27 completed it (14 men, 13 women; mean age, 21.7 years). Fourteen subjects received the test formulation first. No period or sequence effect was observed. The 90% CIs for the corresponding ratios of C(max), AUC(0-t), and AUC(0-infinity) were 80.67 to 107.21, 91.39 to 107.59, and 90.61 to 106.19 (all, P < 0.05). Similar results were found for data without a logarithmic transformation. No AEs were found throughout the study. CONCLUSIONS: In this small study in healthy Mexican volunteers, a single, 500-mg dose of Macrozit was found to be bioequivalent to that of Azitrocin based on the rate and extent of absorption. Both formulations were well tolerated. 相似文献
80.
The Systemic Theory of Living Systems is being published inseveral parts in eCAM. The theory is axiomatic. It originatesfrom the phenomenological idea that physiological health isbased on three factors: integrity of its structure or organization,O, functional organic energy reserve, E, and level of activebiological intelligence, I. From the theory is derived a treatmentstrategy called Systemic Medicine (SM). This is based on identifyingand prescribing phytomedicines and/or other medications thatstrengthen each factor. Energy-stimulating phytomedicines increaseavailable energy and decrease total entropy of an open biologicalsystem by providing negative entropy. The same occurs with phytomedicinesthat act as biological intelligence modulators. They shouldbe used as the first line of treatment in all ailments, sinceall pathologies, by definition, imply a higher than normal organicentropy. SM postulates that the state of health, H, of an individual,is effectively equal to the product of the strength of eachfactor H = O x E x I. SM observes that when all three factorsare brought back to ideal levels, patients' conditions beginthe recovery to normal health. 相似文献